Main findings to be identified by a cardiac sonographer when performing TTE in hypertrophic cardiomyopathy

Authors

  • Paula Andrea Cuartas González Unidad de cardiología no invasiva. Hospital Universitario Mayor-Méderi. Bogotá DC. Colombia

DOI:

https://doi.org/10.37615/retic.v1n3a14

Keywords:

cardiac sonographer, transtoracic echocardiogram, hypertrophic cardiomyopathy without hemodynamic cause.

Abstract

Hypertrophic cardiomyopathy without hemodynamic cause is a cardiac pathology in which the first findings and the follow-up of it are established by transtoracic echocardiography, this being a highly available and cost-effective diagnostic means; For this reason cardiac sonographers who are in primary contact with patients under the supervision of the echocardiographer should be clear about all aspects related to the assessment of this pathology to be able to perform the planning and acquisition of an echocardiographic assessment that the cardiologist echocardiographer will allow during the review of the images to issue an accurate diagnosis that helps in the decision-making process regarding the diagnosis of the patient, treatment, follow-up and use of other cardiac imaging techniques.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Ehler D, Carney D, Dempsey A, et al. Guidelines for cardiac sonographer education: Recommendations of the american society of echocardiography sonographer training and education committee. J Am Soc Echocardiogr. 2001; 14 (1): 77-84.

St Vrain JA, Skelly AC, Waggoner AP, et al. Multiskilling and multicredentialing of the health professional: role of the cardiac sonographer. Sonographer Council of the American Society of Echocardiography. J Am Soc Echocardiogr 1998; (11): 1.090-1.092.

Cardim N., et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging. Endorsed by the Saudi Heart Association. European Heart Journal-Cardiovascular Imaging 2015; 10: 1.093.

Rapezzi C, et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC. Working Group on Myocardial and Pericardial Diseases. European Heart Journal 2012, 10: 1093.

Nagueh SF, et al. American Society of Echocardiography Clinical. Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy. Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular. Computed Tomography.

Goldstein S, Harry M, Carney DK, et al. Outline of sonographer core curriculum in echocardiography: American Society of Echocardiography, sonogra- pher training and education committee. (2002) available in: http://www.columbia.edu/~amk5/core.pdf

Published

2018-12-31

How to Cite

1.
Cuartas González PA. Main findings to be identified by a cardiac sonographer when performing TTE in hypertrophic cardiomyopathy. Rev Ecocardiogr Pract Otras Tec Imag Card (RETIC) [Internet]. 2018 Dec. 31 [cited 2024 Nov. 22];1(3):61-7. Available from: https://imagenretic.org/RevEcocarPract/article/view/105